Could This Backing Help Allergan's CEO Retain His Chairman Role? [Investor's Business Daily]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Investors Business Daily
Related news 4/01/2019 Novartis pledged Monday to spend $1.6 billion to buy a subsidiary of IFM Therapeutics focused on anti-inflammatory drugs. Among its... Why News From J&J, Allergan Could Be A Boon For This Biotech Stock Activist Investor Urges Allergan To Divide CEO-Chairman Role Pfizer, Allergan Stocks Diverge On Earnings Beat, Weak Sales Outlook Biopharmas Restrained In Drug Pricing For 2019 — With These Exceptions This Biotech Stock Is Flying On Its Allergan-Rivaling Migraine Drug Pfizer, Allergan Dive On Cautious 2018 Guidance, Though Profit Tops Allergan Shows Market Leadership With Jump To 84 RS Rating Gilead Disappoints In Liver Disease — But These Rivals Tumbled Instead On Monday, a pair of key shareholder advisory firms backed Allergan 's ( AGN ) decision to allow Chief Executive Brent Saunders to also retain his chairman position. Proxy advisory firms Institutional Shareholder Services and Glass Lewis recommended shareholders vot
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- "FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about them so far. [CBS News]CBS News
- Telesis Bio Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Ulcerative Colitis Treatment Market Size Expected to Reach USD 14.77 Bn by 2033 [Yahoo! Finance]Yahoo! Finance
- Regenex Bio eyes FDA meeting to confirm pivotal DMD trial [Yahoo! Finance]Yahoo! Finance
- This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/9/24 - Form S-8
- 5/8/24 - Form 10-Q
- 5/1/24 - Form 4
- PFE's page on the SEC website